Literature DB >> 15190682

Sources and mechanisms of cytoplasmic oxidative damage in Alzheimer's disease.

Michael Marlatt1, Hyoung-gon Lee, George Perry, Mark A Smith, Xiongwei Zhu.   

Abstract

While evidence supports a pathogenic and proximal role for oxidative stress in Alzheimer's disease, the causes and consequences of reactive oxygen species that promote oxidative damage have not been directly demonstrated. Co-incident with the reduced energy metabolism during the development of the disease, some of the key mitochondrial enzymes have shown deficient activity in AD neurons, which may lead to increased ROS production. However, we found that oxidative damage occurs primarily within the cytoplasm rather than in mitochondria. Given that SOD activity is increased in AD mitochondria and that metal ions such as iron and copper are enriched in susceptible neurons, we hypothesize that mitochondria, as a source, provide hydrogen peroxide, which, as an intermediate, once in the cytoplasm, will be converted into highly reactive hydroxyl radicals through Fenton reaction in the presence of metal ion and cause damage in cytoplasm.

Entities:  

Mesh:

Year:  2004        PMID: 15190682

Source DB:  PubMed          Journal:  Acta Neurobiol Exp (Wars)        ISSN: 0065-1400            Impact factor:   1.579


  13 in total

1.  SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid β protein oligomerization and memory loss in mouse model of Alzheimer disease.

Authors:  Kazuma Murakami; Nakaba Murata; Yoshihiro Noda; Shoichi Tahara; Takao Kaneko; Noriaki Kinoshita; Hiroyuki Hatsuta; Shigeo Murayama; Kevin J Barnham; Kazuhiro Irie; Takuji Shirasawa; Takahiko Shimizu
Journal:  J Biol Chem       Date:  2011-11-09       Impact factor: 5.157

2.  Oxidative stress in the progression of Alzheimer disease in the frontal cortex.

Authors:  Mubeen A Ansari; Stephen W Scheff
Journal:  J Neuropathol Exp Neurol       Date:  2010-02       Impact factor: 3.685

Review 3.  Superoxide dismutases: a physiopharmacological update.

Authors:  A Valdivia; S Pérez-Alvarez; J D Aroca-Aguilar; I Ikuta; J Jordán
Journal:  J Physiol Biochem       Date:  2009-06       Impact factor: 4.158

4.  OGG1 is degraded by calpain following oxidative stress and cisplatin exposure.

Authors:  Jeff W Hill; Jennifer J Hu; Michele K Evans
Journal:  DNA Repair (Amst)       Date:  2008-02-21

5.  Retinoblastoma protein phosphorylation at multiple sites is associated with neurofibrillary pathology in Alzheimer disease.

Authors:  Akanksha Thakur; Sandra L Siedlak; Sheronica L James; David J Bonda; Akanksha Rao; Kate M Webber; Antoni Camins; Mercé Pallàs; Gemma Casadesus; Hyoung-Gon Lee; Robert Bowser; Arun K Raina; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

6.  Amyloid β peptides modify the expression of antioxidant repair enzymes and a potassium channel in the septohippocampal system.

Authors:  Jorge Durán-González; Edna D Michi; Brisa Elorza; Miriam G Perez-Córdova; Luis F Pacheco-Otalora; Ahmed Touhami; Pamela Paulson; George Perry; Ian V Murray; Luis V Colom
Journal:  Neurobiol Aging       Date:  2013-03-07       Impact factor: 4.673

7.  Copper Exposure Perturbs Brain Inflammatory Responses and Impairs Clearance of Amyloid-Beta.

Authors:  Masashi Kitazawa; Heng-Wei Hsu; Rodrigo Medeiros
Journal:  Toxicol Sci       Date:  2016-04-27       Impact factor: 4.849

8.  Formation of the 42-mer Amyloid β Radical and the Therapeutic Role of Superoxide Dismutase in Alzheimer's Disease.

Authors:  Kazuma Murakami; Takahiko Shimizu; Kazuhiro Irie
Journal:  J Amino Acids       Date:  2011-01-16

9.  Redox processes in neurodegenerative disease involving reactive oxygen species.

Authors:  Peter Kovacic; Ratnasamy Somanathan
Journal:  Curr Neuropharmacol       Date:  2012-12       Impact factor: 7.363

Review 10.  Therapeutic potential of astaxanthin and superoxide dismutase in Alzheimer's disease.

Authors:  Vyshnavy Balendra; Sandeep Kumar Singh
Journal:  Open Biol       Date:  2021-06-30       Impact factor: 6.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.